An observational study in Type 2 Diabetes, sponsored by University of Tromso. Completed at 1 site in Norway. Open to participants aged 20 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2011-07-20.
Sponsored by University of Tromso · Observational
Following the 6th Tromso study subjects with HbA1c > 5.7 plus a subsample of subjects with lower hba1c values will be invited to an oral glucose tolerance test to see the predictive value of HBA1c in the diagnosis of type 2 diabetes.
10,925 studies on the registry are indexed under Diabetes Mellitus; 1,319 are open to participants now.
This study's enrollment of 3,509 is above the median of 233 across 2,220 observational studies indexed under Diabetes Mellitus.
Browse Diabetes Mellitus studies →University of Tromso is the lead sponsor of 61 studies on the registry; 7 are open to participants now.
Counted across the registry records on this site, refreshed daily.
random sample of subjects living in Tromso and who participated in the 6 th Tromsø study
Exclusion Criteria:
Number of subjects with new diagnosis of type 2 diabetes
Time frame: Up to 2 years after participation in the 6th Tromso study
Number of subjects with new diagnosis of impaired glucose tolerance
Time frame: Up to 2 years after participation in the 6th Tromso study
Number of subjects with new diagnosis of impaired fasting glucose
Time frame: Up to 2 years after participation in the 6th Tromso study
Effect of vitamin D status on glucose tolerance
Time frame: Up to 2 years after participation in the 6th Tromso study
This study is completed, as verified in Jul 2011. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Tromso